双鹭药业股价小幅回落 中报预增237%至356%

Group 1 - The stock price of Shuanglu Pharmaceutical closed at 8.31 yuan on August 5, 2025, down 0.95% from the previous trading day [1] - The trading volume on that day was 269,722 hands, with a transaction amount of 225 million yuan [1] - Shuanglu Pharmaceutical is primarily engaged in the research, development, production, and sales of biopharmaceuticals, covering areas such as genetic engineering drugs, biochemical drugs, and chemical drugs [1] Group 2 - The company expects a net profit attributable to shareholders of 100 million to 135 million yuan for the first half of 2025, representing a year-on-year increase of 237.95% to 356.24% [1] - This performance forecast has introduced the "2025 interim report pre-increase" concept for the company [1] - On August 5, the net outflow of main funds for Shuanglu Pharmaceutical was 33.4665 million yuan, with a cumulative net outflow of 167 million yuan over the past five trading days [1]